Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
NCT01982916 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 324
Last updated 2018-03-13
Summary
The purpose of this study is to evaluate treatment of perennial allergic rhinitis in Korean patients with AGR tablet.
Conditions
- Allergic Rhinitis
- Perennial Allergic Rhinitis
- Non-seasonal Allergic Rhinitis
Interventions
- DRUG
-
AGR tablet
- DRUG
-
Placebo (for AGR tablet and/or Active Comparator)
- DRUG
-
Active Comparator
Sponsors & Collaborators
-
Seoul National University Bundang Hospital
collaborator OTHER -
Seoul National University Hospital
collaborator OTHER -
SMG-SNU Boramae Medical Center
collaborator OTHER -
Samsung Medical Center
collaborator OTHER -
Kyunghee University Medical Center
collaborator OTHER -
Konkuk University Medical Center
collaborator OTHER -
Inha University Hospital
collaborator OTHER -
Seoul St. Mary's Hospital
collaborator OTHER -
Severance Hospital
collaborator OTHER -
Ahn-Gook Pharmaceuticals Co.,Ltd
lead INDUSTRY
Principal Investigators
-
Chae-Seo Rhee, M.D. · Seoul National University Bundang Hospital
-
Tae-Bin Won, M.D. · Seoul National University Hospital
-
Dae-Woo Kim, M.D. · SMG-SNU Boramae Medical Center
-
Hyo-Yeol Kim, M.D. · Samsung Medical Center
-
Sung-Wan Kim, M.D. · Kyunghee University Medical Center
-
Jin-Kook Kim, M.D. · Konkuk University Medical Center
-
Young-Hyo Kim, M.D. · Inha University Hospital
-
Soo-Whan Kim, M.D. · Seoul St. Mary's Hospital
-
Chang-Hoon Kim, M.D. · Severance Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
Clinical Trial to Evaluate the Safety and Efficacy of "CITUS Dry Syrup" in Children With Perennial Allergic Rhinitis
NCT01539304 ·Status: COMPLETED ·Phase: PHASE3
-
Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis
NCT01400828 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis
NCT05922176 ·Status: RECRUITING
-
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
NCT07154342 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis
NCT06577077 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
NCT05525650 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
NCT01241214 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
NCT01484119 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of Perennial Allergic Rhinitis
NCT00358475 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.
NCT07199257 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).
NCT06315426 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
NCT02654223 ·Status: COMPLETED ·Phase: PHASE2
-
Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis
NCT05098522 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
NCT01640535 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment
NCT00773240 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy
NCT01555736 ·Status: COMPLETED ·Phase: PHASE4
-
Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study
NCT02005627 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Air Cleaner on the Indoor Allergen Sensitized Allergic Rhinitis Patients
NCT03313453 ·Status: COMPLETED ·Phase: NA
-
Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis
NCT04088721 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients
NCT06890572 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
NCT03293225 ·Status: COMPLETED
-
Efficacy and Safety of HCP1102 Capsule
NCT02552667 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients
NCT00857779 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of the ALK Grass Tablet in Subjects With Hayfever
NCT00227279 ·Status: COMPLETED ·Phase: PHASE3